I have high blood pressure and it's my hope that moving to a zero nicotine vape will help to lower my blood pressure in the long run.
It is nicotine in combination with SMOKE (and especially the resulting carbon monoxide) that causes all the harm. Here are a few more resources on this topic, all of which I have cited to over and over again in the past couple of years on this forum.
From
OASAS Events
"MYTH 13: Wearing a patch will bring on cardiovascular (heart) disease?
TRUTH: NRT’s can be used safely by the majority of people with cardiovascular
disease, even with concomitant smoking. 1-3 A meta-analysis shows no difference
in the rate of acute heart attacks when a NRT patch is worn versus wearing a
placebo patch. 4 The benefits of NRT outweigh the risks, even in smokers with
cardiovascular disease.
1 Joseph AM, et al. N Engl J Med 1996; 335:1792–1798.
2 Tzivoni D, et al. Cardiovasc Drugs Ther 1998; 12:239–244.
3 Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease.
Arch Intern Med 1994; 154:989–995.
4 Greenland S, et al. Drug Saf 1998; 18: 297–308"
Neal L. Benowitz, MD, from
http://content.onlinejacc.org/cgi/re...791.pdf?ck=nck:
"Overall, the epidemiologic and experimental data suggest
that nicotine absorbed from smokeless tobacco, nicotine
gum or transdermal nicotine is not a significant risk factor
for accelerating coronary artery disease or causing acute
cardiovascular events."
And from Harm Reduction Journal HRJ | Full text | Tobacco harm reduction: an alternative cessation strategy for inveterate smokers
"Over the past 15 years, eight epidemiologic studies have examined the risk of cardiovascular diseases among ST users. Six of the studies found that ST users had no increased risk for heart attacks or strokes [47,90,97-100] . The other two reported modestly positive associations, with ST users having RRs of 1.2 and 1.4 [92,101] , which are lower than those of smokers. In 2003, Asplund completed a comprehensive review of the cardiovascular effects of ST use [102] . He concluded that, in distinct contrast to smokers, ST users do not exhibit any significant differences from nonusers of tobacco with regard to the following measures of cardiovascular health: heart rate, blood pressure, cardiac output and maximal working capacity, levels of hemoglobin and hematocrit, leukocytes, antioxidant vitamins, fibrinogen, components of the fibrinolytic system, C-reactive protein and thromboxane A2 production. In addition, ST users did not show important smoking-associated vascular changes, including increased thickness of blood vessels and atherosclerotic plaque development. In summary, most of the medical and epidemiologic evidence documents that ST users do not have elevated risks for cardiovascular diseases."
